Analyst Ratings for Lipocine Inc (LPCN)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/24/2021 | Cantor Fitzgerald » Updated 8/8/2022 |
Jennifer Kim | New Coverage | Overweight (N/A) |
2.00 (3.00) |
1.36 (4.53) |
233.09% | Details |
| 12/10/2020 | Ladenburg Thalmann » Updated 11/10/2022 |
Matthew L. Kaplan | Upgrade | Buy (Neutral) |
4.00 (2.50) |
1.32 (4.53) |
243.18% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
